Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Wittebol, S.

Search results

  • RSS Feed
(1 - 9 of 9)
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Kater, A.P.; Oers, M.H.J. van; Norden, Y. van; Straten, L. van der; Driessen, J.; Posthuma, W.F.M.; ... ; HOVON CLL Study Grp 2019
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Article / Letter to editor
metadata only
The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
Vojdeman, F.J.; van't Veer, M.B.; Tjonnfjord, G.E.; Itala-Remes, M.; Kimby, E.; Polliack, A.; ... ; Geisler, C.H. 2017
The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia
Article / Letter to editor
metadata only
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
Vojdeman, F.J.; Herman, S.E.M.; Kirkby, N.; Wiestner, A.; t' Veer, M.B. van; Tjonnfjord, G.E.; ... ; Niemann, C.U. 2017
Soluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
Article / Letter to editor
open access
PERFORMANCE STATUS AND COMORBIDITY AFFECT SURVIVAL IN ELDERLY PATIENTS WITH CLL AFTER LOW DOSE ALEMTUZUMAB COMBINED WITH CHEMOTHERAPY: RESULTS FROM THE HOVON68 TRIAL
Vojdeman, F.; van't Veer, M.; Tjonnfjord, G.; Itala-Remes, M.; Kimby, E.; Polliack, A.; ... ; Geisler, C. 2016
PERFORMANCE STATUS AND COMORBIDITY AFFECT SURVIVAL IN ELDERLY PATIENTS WITH CLL AFTER LOW DOSE ALEMTUZUMAB COMBINED WITH CHEMOTHERAPY: RESULTS FROM THE HOVON68 TRIAL
Article / Letter to editor
metadata only
Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial
Kersting, S.; Levin, M.D.; Chamuleau, M.; Daenen, S.M.G.J.; Dompeling, E.C.; Doorduijn, J.K.; ... ; Dutch Belgium HOVON CLL Working 2016
Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemial
Article / Letter to editor
metadata only
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
Zwaginga, J.J.; Holt, B. van der; Boekhorst, P.A. te; Biemond, B.J.; Levin, M.D.; Griend, R. van der; ... ; Dutch HOVON 64 Study Grp 2015
Multi-center randomized open label phase II trial on three rituximab dosing schemes in immune thrombocytopenia patients
Article / Letter to editor
metadata only
Real-world costs of chronic lymphocytic leukaemia in the Netherlands
Holtzer-Goor, K.M.; Bouwmans-Frijters, C.A.M.; Schaafsma, M.R.; Weerdtc, O. de; Joosten, P.; Posthuma, E.F.M.; ... ; Uyl-de Groot, C.A. 2014
Real-world costs of chronic lymphocytic leukaemia in the Netherlands
Article / Letter to editor
metadata only
Phase 1/2 Trial Of Lenalidomide In Combination With Cyclophosphamide and Prednisone (REP) In Patients With Lenalidomide-Refractory Multiple Myeloma (REPEAT-study)
Nijhof, I.S.; Zweegman, S.; Levin, M.D.; Koene, H.R.; Beeker, A.; Bloem, A.C.; ... ; Donk, N.W.C.J. van de 2013
Phase 1/2 Trial Of Lenalidomide In Combination With Cyclophosphamide and Prednisone (REP) In Patients With Lenalidomide-Refractory Multiple Myeloma (REPEAT-study)
Article / Letter to editor
metadata only
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Deenik, W.; Janssen, J.J.W.M.; Holt, B. van der; Verhoef, G.E.G.; Smit, W.M.; Kersten, M.J.; ... ; Cornelissen, J.J. 2010
Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia
Article / Letter to editor
metadata only